{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:50:37Z","timestamp":1772142637633,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T00:00:00Z","timestamp":1460073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T00:00:00Z","timestamp":1467849600000},"content-version":"vor","delay-in-days":90,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["setac.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>\u2003<\/jats:title><jats:p>The water constituents that are currently subject to legal control are only a small fraction of the vast number of chemical substances and microorganisms that may occur in both the environment and water resources. The main objective of the present study was to study the health impact resulting from exposure to a mixture of pharmaceuticals that have been detected in tap water at low doses. Analyses of atenolol, caffeine, erythromycin, carbamazepine, and their metabolites in blood, urine, feces, fat tissue, liver, and kidney after exposure to a mixture of these pharmaceuticals in treated drinking water were performed. The effects of this exposure were assessed in rats by measuring biochemical markers of organ injury or dysfunction. Simultaneously, the selected pharmaceuticals were also quantified in both physiological fluids and organ homogenates by liquid chromatography\u2013tandem mass spectrometry (performed in multiple reaction monitoring mode and full scan mode). Following exposure of rats to a concentration of a pharmaceutical which was 10 times higher than the concentration known to be present in tap water, trace levels of some pharmaceuticals and their metabolites were detected in biological samples. This exposure did, however, not lead to significant organ injury or dysfunction. Thus, the authors report an experimental model that can be used to characterize the safety profile of pharmaceuticals in treated drinking water using a multiorgan toxicity approach. Environ Toxicol Chem 2016;35:2674\u20132682. \u00a9 2016 SETAC<\/jats:p><\/jats:sec>","DOI":"10.1002\/etc.3451","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T18:31:37Z","timestamp":1460313097000},"page":"2674-2682","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Chemical and biochemical characterization and in vivo safety evaluation of pharmaceuticals in drinking water"],"prefix":"10.1093","volume":"35","author":[{"given":"Vanessa","family":"de Jesus Gaffney","sequence":"first","affiliation":[{"name":"Institute for Medicines and Pharmaceutical Sciences (iMed.UL) Lisbon Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helder","family":"Mota-Filipe","sequence":"additional","affiliation":[{"name":"Department of Social PharmacyFaculty of PharmacyUniversity of Lisbon Lisbon Portugal"},{"name":"Institute for Medicines and Pharmaceutical Sciences (iMed.UL) Lisbon Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Amaro","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Pharmacological SciencesFaculty of PharmacyUniversity of Lisbon Lisbon Portugal"},{"name":"Institute for Medicines and Pharmaceutical Sciences (iMed.UL) Lisbon Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Thiemermann","sequence":"additional","affiliation":[{"name":"The William Harvey Research InstituteQueen Mary University of London, Barts and the London School of Medicine and Dentistry London United Kingdom"},{"name":"Institute for Medicines and Pharmaceutical Sciences (iMed.UL) Lisbon Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Loureiro","sequence":"additional","affiliation":[{"name":"Empresa Portuguesa das \u00c1guas LivresS.A.Laboratories and Water Quality Control Department Lisbon Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor Vale","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Empresa Portuguesa das \u00c1guas LivresS.A.Laboratories and Water Quality Control Department Lisbon Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jo\u00e3o","family":"Benoliel","sequence":"additional","affiliation":[{"name":"Empresa Portuguesa das \u00c1guas LivresS.A.Laboratories and Water Quality Control Department Lisbon Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina M.M.","family":"Almeida","sequence":"additional","affiliation":[{"name":"Department of Toxicological and Bromatological SciencesFaculty of PharmacyUniversity of Lisbon Lisbon Portugal"},{"name":"Institute for Medicines and Pharmaceutical Sciences (iMed.UL) Lisbon Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"2025010315193303600_etc3451-bib-0001","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.embor.7400307","article-title":"The environmental side effects of medication","volume":"5","author":"Boxall","year":"2004","journal-title":"EMBO Rep"},{"key":"2025010315193303600_etc3451-bib-0002","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11356-011-0614-1","article-title":"Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants","volume":"19","author":"Rua-Gomez","year":"2012","journal-title":"Environ Sci Pollut Res Int"},{"key":"2025010315193303600_etc3451-bib-0003","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1039\/c2em10950f","article-title":"Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater","volume":"14","author":"Rua-Gomez","year":"2012","journal-title":"J Environ Monit"},{"key":"2025010315193303600_etc3451-bib-0004","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1039\/C4EM00583J","article-title":"Correlation of trace contaminants to wastewater management practices in small watersheds","volume":"17","author":"Schenck","year":"2015","journal-title":"Environ Sci Process Impacts"},{"key":"2025010315193303600_etc3451-bib-0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.scitotenv.2014.12.067","article-title":"Concentrations of hormones, pharmaceuticals and other micropollutants in groundwater affected by septic systems in New England and New York","volume":"512","author":"Phillips","year":"2015","journal-title":"Sci Total Environ"},{"key":"2025010315193303600_etc3451-bib-0006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-environ-052809-161223","article-title":"Pharmaceuticals in the environment","volume":"35","author":"Kummerer","year":"2010","journal-title":"Annu Rev Environ Resour"},{"key":"2025010315193303600_etc3451-bib-0007","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/etc.2085","article-title":"Diclofenac: New data on chronic toxicity and bioconcentration in fish","volume":"32","author":"Memmert","year":"2013","journal-title":"Environ Toxicol Chem"},{"key":"2025010315193303600_etc3451-bib-0008","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/10643380903140224","article-title":"Environmental risk assessment of emerging pollutants in water: Approaches under horizontal and vertical EU legislation","volume":"41","author":"Hernando","year":"2011","journal-title":"Crit Rev Environ Sci Technol"},{"key":"2025010315193303600_etc3451-bib-0009","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jenvman.2009.01.023","article-title":"The presence of pharmaceuticals in the environment due to human use\u2014Present knowledge and future challenges","volume":"90","author":"Kummerer","year":"2009","journal-title":"J Environ Manage"},{"key":"2025010315193303600_etc3451-bib-0010","author":"World Health Organization.","year":"2011"},{"key":"2025010315193303600_etc3451-bib-0011","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1590\/S0100-40422014000100023","article-title":"Analysis of pharmaceutical compounds in waters by SPE-UPLC-ESI-MS\/MS","volume":"37","author":"Gaffney","year":"2014","journal-title":"Quim Nova"},{"key":"2025010315193303600_etc3451-bib-0012","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4236\/jwarp.2010.29097","article-title":"Experimental and statistical validation of several endocrine disrupters by solid-phase extraction, liquid chromatography tandem mass spectrometry","volume":"2","author":"Henriques","year":"2010","journal-title":"Journal of Water Resource and Protection"},{"key":"2025010315193303600_etc3451-bib-0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.chemosphere.2006.12.057","article-title":"Experimental and statistical validation of SPME-GC-MS analysis of phenol and chlorophenols in raw and treated water","volume":"68","author":"Simoes","year":"2007","journal-title":"Chemosphere"},{"key":"2025010315193303600_etc3451-bib-0014","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.watres.2014.10.027","article-title":"Occurrence of pharmaceuticals in a water supply system and related human health risk assessment","volume":"72","author":"Gaffney","year":"2015","journal-title":"Water Res"},{"key":"2025010315193303600_etc3451-bib-0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1258\/0023677041958945","article-title":"Experimental animal urine collection: A review","volume":"38","author":"Kurien","year":"2004","journal-title":"Laboratory Animals"},{"key":"2025010315193303600_etc3451-bib-0016","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute for Laboratory Animal Research, Division on Earth and Life Studies.","year":"2011","edition":"8th ed"},{"key":"2025010315193303600_etc3451-bib-0017","first-page":"L 276\/33","article-title":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes","author":"European Commission.","year":"2010","journal-title":"Official Journal of the European Union"},{"key":"2025010315193303600_etc3451-bib-0018","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jms.785","article-title":"Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography\/tandem mass spectrometry","volume":"40","author":"Weimann","year":"2005","journal-title":"J Mass Spectrom"},{"key":"2025010315193303600_etc3451-bib-0019","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jchromb.2013.11.054","article-title":"A sensitive HPLC-MS\/MS method for the determination of dolutegravir in human plasma","volume":"945","author":"Bennetto-Hood","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2025010315193303600_etc3451-bib-0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jaoac\/92.1.359","article-title":"Determination of 17alpha-ethynylestradiol, carbamazepine, diazepam, simvastatin, and oxybenzone in fish livers","volume":"92","author":"Kwon","year":"2009","journal-title":"J AOAC Int"},{"key":"2025010315193303600_etc3451-bib-0021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jchromb.2013.06.033","article-title":"Simultaneous determination of trantinterol and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry","volume":"934","author":"Li","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2025010315193303600_etc3451-bib-0022","first-page":"275","article-title":"Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography mass spectrometry","volume":"25","author":"Maggs","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"2025010315193303600_etc3451-bib-0023","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0090-9556(25)07375-1","article-title":"Bioactivation of carbamazepine in the rat in vivo\u2014Evidence for the formation of reactive arene oxide(s)","volume":"24","author":"Madden","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"2025010315193303600_etc3451-bib-0024","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000401062","article-title":"Pharmacokinetics of erythromycin in man","volume":"25","author":"Wilson","year":"1978","journal-title":"Antibiot Chemother (1971)"},{"key":"2025010315193303600_etc3451-bib-0025","author":"CEVA Sant\u00e9 Animale.","year":"2003"},{"key":"2025010315193303600_etc3451-bib-0026","first-page":"920","article-title":"Tissue distribution of erythromycin in rats","volume":"3","author":"Lee","year":"1953","journal-title":"Antibiot Chemother (Northfield)"},{"key":"2025010315193303600_etc3451-bib-0027","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhazmat.2012.10.039","article-title":"Photodegradation kinetics and transformation products of ketoprofen, diclofenac and atenolol in pure water and treated wastewater","volume":"244","author":"Salgado","year":"2013","journal-title":"J Hazard Mater"},{"key":"2025010315193303600_etc3451-bib-0028","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/bmc.736","article-title":"In vivo evaluation of CYP1A2 CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios","volume":"21","author":"Begas","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"2025010315193303600_etc3451-bib-0029","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(72)90397-8","article-title":"Tissues distribution of caffeine and its metabolites in mouse","volume":"21","author":"Burg","year":"1972","journal-title":"Biochem Pharmacol"},{"key":"2025010315193303600_etc3451-bib-0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1007976831684","article-title":"Recent advances in caffeine and theobromine toxicities: A review","volume":"51","author":"Eteng","year":"1997","journal-title":"Plant Food Hum Nutr"},{"key":"2025010315193303600_etc3451-bib-0031","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1289\/ehp.1206244","article-title":"Pharmaceuticals in tap water: Human health risk assessment and proposed monitoring framework in China","volume":"121","author":"Leung","year":"2013","journal-title":"Environ Health Perspect"},{"key":"2025010315193303600_etc3451-bib-0032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.scitotenv.2012.04.010","article-title":"Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water","volume":"427","author":"Jongh","year":"2012","journal-title":"Sci Total Environ"}],"container-title":["Environmental Toxicology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fetc.3451","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/etc\/article-pdf\/35\/11\/2674\/60107660\/etc3451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/etc\/article-pdf\/35\/11\/2674\/60107660\/etc3451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:59:07Z","timestamp":1748861947000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/etc\/article\/35\/11\/2674\/7741757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,8]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,4,8]]},"published-print":{"date-parts":[[2016,4,8]]}},"URL":"https:\/\/doi.org\/10.1002\/etc.3451","relation":{},"ISSN":["0730-7268","1552-8618"],"issn-type":[{"value":"0730-7268","type":"print"},{"value":"1552-8618","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11,1]]},"published":{"date-parts":[[2016,4,8]]},"assertion":[{"value":"2016-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}